Edison Ponari

Edison is a corporate lawyer at Lander & Rogers. He has a strong and well-rounded corporate practice, with particular depth in equity capital markets and complex transactional work.

Edison regularly advises on business and share sales and acquisitions, IPOs, secondary capital raisings and private capital raises across a broad range of sectors, including technology (cloud and cyber), pharmaceuticals and life sciences, consumer hardware and marketing services. He is frequently engaged as lead associate, coordinating multi-disciplinary teams, managing transaction timetables and serving as a key contact for clients and external stakeholders.

Experience

Edison’s work is focused on transaction delivery, including coordinating legal due diligence, acting as secretary to due diligence committees and preparing offer-related documentation. He drafts key transaction and disclosure materials and advises clients and advisers on disclosure, structuring and execution issues as they arise during a transaction. Edison works closely with management teams, advisers and regulators to manage tight timetables and keep capital raisings progressing efficiently from launch through to completion. He also advises on complex commercial contracts, compliance with legal and regulatory frameworks, and general corporate matters.

Edison’s areas of expertise include:

• equity capital markets, including IPOs, pre-IPO capital raisings, secondary raisings and private placements on ASX
• mergers and acquisitions, including share and asset acquisitions and disposals across a broad range of sectors
• ASX Listing Rules compliance, including ASIC and ASX waiver applications, in-principle advice applications and escrow requirements
• corporate governance, including drafting governance documents and advising on ASX Corporate Governance Recommendations
• legal due diligence, commercial contracts and general corporate advisory.

Career highlights

Edison’s career highlights include:

• lead associate advising 6K Additive, Inc. (ASX:6KA), a US-based advanced materials company, on its $22 million pre-IPO capital raise and $48 million capital raising associated with its ASX IPO
• lead associate advising a clinical-stage Australian biotech company on its A$7.7 million pre-IPO capital raise and proposed ASX listing, including managing legal due diligence and the ASX listing application
• supporting associate advising Clarity Pharmaceuticals Ltd (ASX:CU6) on its A$121 million private placement and accelerated non-renounceable pro-rata entitlement offer
• lead associate advising Smart Parking Limited, Fluence Corporation Limited, Cann Group, Spirit Technology Solutions, Optima Technology Group and Visionflex Limited on their respective private placements and accelerated non-renounceable pro-rata entitlement offers
• lead associate advising Pier 12 Capital Limited (formerly Auctus Investment Group Limited) on its voluntary delisting from the ASX
• lead associate advising a global technology services company on its acquisition of a cybersecurity business and vendor due diligence for the proposed sale of its data centre assets and business
• supporting associate advising Reece Group on multiple bolt-on acquisitions across the pool products, water infrastructure and fire protection sectors
• supporting associate advising a media services group on its acquisitions of two full-service media agencies in Australia, including conducting due diligence, drafting sale documentation and coordinating transaction close
• lead associate advising companies across the insect-based manufacturing technology, life sciences, pharmaceuticals and medical technology sectors on their respective convertible note fundraising rounds, angel round equity raisings and Series A capital raisings.